Barinthus Biotherapeutics (BRNS) Minority Interest (2020 - 2026)
Barinthus Biotherapeutics' Minority Interest came in at $61,000 for Q2 2026, down 41.3% from $104,000 a year earlier and down 22.8% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Minority Interest (2020 - 2026) Analysis & Trends
At the end of FY2025, Barinthus Biotherapeutics' Minority Interest was $84,000, down 20.8% from FY2024.
- Minority Interest has declined in each of the last four years, with a five-year compound annual growth rate of -26.5% (FY2020 to FY2025).
- Going back by year, Minority Interest was $106,000 in FY2024 (-49.8%), $211,000 in FY2023 (-30.8%), $305,000 in FY2022 (-30.2%) and $437,000 in FY2021 (+11.8%).
- The Q2 2026 figure represents the lowest quarterly Minority Interest in data going back to Q1 2020.
- Year-over-year, Minority Interest has declined for 17 consecutive quarters, with an average decline of 34.8% over the last eight quarters.
- The fastest year-over-year change in Minority Interest over five years came in Q1 2022 (growth of 44.4%), and the weakest in Q3 2021 (a decline of 98.5%).
- Business Quant data shows BRNS's Minority Interest at $79,000 (Q1 2026), $84,000 (Q4 2025) and $96,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 211,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 268,000.00 |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 315,000.00 |
| Jun 30, 2022 | 366,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 437,000.00 |
| Sep 30, 2021 | 493,000.00 |
API Access
Barinthus Biotherapeutics Minority Interest API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=minority-interest&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "minority-interest", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=minority-interest&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();